Gordon Kuntz, VP Pathways and Consulting Partner
Gordon’s expertise includes over 15 years working in the cancer space for a variety of companies directly and as a consultant. By working with patients, large and small community practices, hospital-based practices, NCI Cancer Centers, drug distribution, drug manufacturers, pathways companies, health plans, PBMs, specialty pharmacies, technology companies and many others, Kuntz Consulting has developed a unique understanding of the cancer care ecosystem.
Since 2004, Gordon has worked with oncology clinical pathways for a variety of organizations, including US Oncology, ION Solutions/AmerisourceBergen, Via Oncology/Elsevier, and a large NCI Cancer Center with their own pathways. A member of the editorial board of the Journal of Clinical Pathways, he has contributed numerous articles and moderated the 2019 and 2020 Clinical Pathways Congress.